Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02384421 · ClinicalTrials.gov registry record · NA
Adaptive Closed Loop Neuromodulation and Neural Signatures of Parkinson's Disease
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT02384421: Completed NA study, sponsored by Stanford University.
NCT02384421 is a NA study that has completed, run by Stanford University. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02384421, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
Continuous deep brain stimulation (cDBS) is an established therapy for the major motor signs in Parkinson's disease. Currently, cDBS is limited to "open-loop" stimulation, without real-time adjustment to the patient's state of activity, fluctuations and types of motor symptoms, medication dosages, or neural markers of the disease. The purpose of this study is to determine if an adaptive DBS system, responding to patient specific, clinically relevant neural or kinematic feedback, is efficacious on the motor Unified Parkinson's Disease Rating Scale (UPDRS III) and specific phenotypic measures in Parkinson's Disease compared to OFF therapy (i.e., OFF DBS and withdrawn from medication) and more efficient than cDBS. Not every recruited participant completed every part of the protocol.
Interventions
- DEVICE Adaptive DBS (Activa PC+S Neurostimulator)
- DEVICE Continuous DBS (Activa PC+S Neurostimulator)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2015-01 |
| Est. Completion | 2021-08-16 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02384421
The ClinicalTrials.gov registry entry for NCT02384421 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Adaptive DBS (Activa PC+S Neurostimulator) is the first listed.
NCT02384421 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02384421 about?
NCT02384421 is a clinical study titled "Adaptive Closed Loop Neuromodulation and Neural Signatures of Parkinson's Disease". Continuous deep brain stimulation (cDBS) is an established therapy for the major motor signs in Parkinson's disease. Currently, cDBS is limited to "open-loop" stimulation, without real-time adjustment to the patient's state of activity, fluctuations and types of motor symptoms, medication dosages, o...
What is the current status of trial NCT02384421?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2015-01. Estimated completion is 2021-08-16.
What interventions are being tested in trial NCT02384421?
The interventions under investigation include: Adaptive DBS (Activa PC+S Neurostimulator) (DEVICE), Continuous DBS (Activa PC+S Neurostimulator) (DEVICE).
Who is sponsoring clinical trial NCT02384421?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.